Condition

Isocitrate Dehydrogenase (1)

Leukemia, Myeloid (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Celgene (1)

Collaborator

Intervention

ag-221 (1)

azacitidine (1)

bsc (1)

intermediate-dose cytarabine (idac) (1)

low-dose cytarabine (ldac) (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

isocitrate dehydrogenase

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Leukemia, Myeloid, Isocitrate Dehydrogenase Trial in Worldwide (AG-221, BSC, Azacitidine)

Active, not recruiting

Leukemia, Myeloid
Isocitrate Dehydrogenase

AG-221
+4 more

Los Angeles, California
+145 more

Jun 7, 2022